Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor

J Oncol Pract. 2015 Sep;11(5):363-4. doi: 10.1200/JOP.2015.005397. Epub 2015 Aug 4.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use*
  • Bevacizumab / adverse effects*
  • Bevacizumab / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab